Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

S Shivananda, J Lennard-Jones, R Logan, N Fear, A Price, L Carpenter, M van Blankenstein

Department of Internal Medicine, University Hospital, Maastricht, The Netherlands.

BACKGROUND: It has been suggested that the incidence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is three or more times higher in northern than in southern Europe. The aim of this EC funded study was to investigate this apparent variation by ascertaining the incidence of IBD across Europe. METHODS: For the period 1 October 1991 to 30 September 1993 all new patients diagnosed with IBD were prospectively identified in 20 European centres according to a standard protocol for case ascertainment and definition. FINDINGS: Altogether 2201 patients aged 15 years or more were identified, of whom 1379 were diagnosed as UC (including proctitis), 706 as CD, and 116 as indeterminate. The overall incidence per 100,000 at ages 15-64 years (standardised for age and sex) of UC was 10.4 (95% confidence interval (95% CI) 7.6 to 13.1) and that of CD was 5.6 (95% CI 2.8 to 8.3). Rates of UC in northern centres were 40% higher than those in the south (rate ratio (RR) = 1.4 (95% CI 1.2 to 1.5)) and for CD they were 80% higher (RR = 1.8 (95% CI 1.5 to 2.1)). For UC the highest reported incidence was in Iceland (24.5, 95% CI 17.4 to 31.5) and for CD, Maastricht (The Netherlands; 9.2, 95% CI 6.5 to 11.8) and Amiens (north west France; 9.2, 95% CI 6.3 to 12.2). The lowest incidence of UC was in Almada (southern Portugal) (1.6, 95% CI 0.0 to 3.2) and of CD in Ioannina (north west Greece) (0.9, 95% CI 0.0 to 2.2). An unexpected finding was a difference in the age specific incidence of UC in men and women with the incidence in women but not men declining with age. INTERPRETATION: The higher overall incidence rates in northern centres did not seem to be explained by differences in tobacco consumption or education. Nevertheless, the magnitude of the observed excess for both conditions is less than expected on the basis of previous studies. This may reflect recent increases in the incidence of IBD in southern Europe whereas those in the north may have stabilised.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• The IBD in EPIC Study Investigators, (2009). Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 58: 1606-1611 [Abstract] [Full Text]  
• KUMAR, P, DOMJAN, J, BHANDARI, P, ELLIS, R, HIGGINSON, A (2009). Is there an association between intestinal perfusion and Crohn's disease activity? A feasibility study using contrast-enhanced ultrasound. Br. J. Radiol. 82: 112-117 [Abstract] [Full Text]  
• Romano, C., Famiani, A., Gallizzi, R., Comito, D., Ferrau', V., Rossi, P. (2008). Indeterminate Colitis: A Distinctive Clinical Pattern of Inflammatory Bowel Disease in Children. Pediatrics 122: e1278-e1281 [Abstract] [Full Text]  
• Bernstein, C. N, Shanahan, F. (2008). Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 57: 1185-1191 [Full Text]  
• Hoie, O, Schouten, L J, Wolters, F L, Solberg, I C, Riis, L, Mouzas, I A, Politi, P, Odes, S, Langholz, E, Vatn, M, Stockbrugger, R W, Moum, B, on behalf of the European Collaborative Study Grou, (2007). Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut 56: 497-503 [Abstract] [Full Text]  
• Williams, J G, Roberts, S E, Ali, M F, Cheung, W Y, Cohen, D R, Demery, G, Edwards, A, Greer, M, Hellier, M D, Hutchings, H A, Ip, B, Longo, M F, Russell, I T, Snooks, H A, Williams, J C (2007). Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut 56: 1-113 [Full Text]  
• Green, C., Elliott, L., Beaudoin, C., Bernstein, C. N. (2006). A Population-based Ecologic Study of Inflammatory Bowel Disease: Searching for Etiologic Clues. Am J Epidemiol 164: 615-623 [Abstract] [Full Text]  
• Wolters, F L, Russel, M G, Sijbrandij, J, Ambergen, T, Odes, S, Riis, L, Langholz, E, Politi, P, Qasim, A, Koutroubakis, I, Tsianos, E, Vermeire, S, Freitas, J, van Zeijl, G, Hoie, O, Bernklev, T, Beltrami, M, Rodriguez, D, Stockbrugger, R W, Moum, B, on behalf of the European Collaborative Study Grou, (2006). Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut 55: 1124-1130 [Abstract] [Full Text]  
• Jaskowski, T. D., Litwin, C. M., Hill, H. R. (2006). Analysis of Serum Antibodies in Patients Suspected of Having Inflammatory Bowel Disease. CVI 13: 655-660 [Abstract] [Full Text]  
• Lakatos, L, Lakatos, P L (2006). Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?. Postgrad. Med. J. 82: 332-337 [Abstract] [Full Text]  
• Loftus, E V Jr (2006). Crohn's disease: why the disparity in mortality?. Gut 55: 447-449 [Full Text]  
• Wolters, F L, Russel, M G, Sijbrandij, J, Schouten, L J, Odes, S, Riis, L, Munkholm, P, Bodini, P, O'Morain, C, Mouzas, I A, Tsianos, E, Vermeire, S, Monteiro, E, Limonard, C, Vatn, M, Fornaciari, G, Pereira, S, Moum, B, Stockbrugger, R W, on behalf of the European Collaborative study grou, (2006). Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut 55: 510-518 [Abstract] [Full Text]  
• Stange, E F, Travis, S P L, Vermeire, S, Beglinger, C, Kupcinkas, L, Geboes, K, Barakauskiene, A, Villanacci, V, Von Herbay, A, Warren, B F, Gasche, C, Tilg, H, Schreiber, S. W, Scholmerich, J, Reinisch, W, for the European Crohn's and Colitis Organisation, (2006). European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 55: i1-i15 [Full Text]  
• Baron, S, Turck, D, Leplat, C, Merle, V, Gower-Rousseau, C, Marti, R, Yzet, T, Lerebours, E, Dupas, J-L, Debeugny, S, Salomez, J-L, Cortot, A, Colombel, J-F (2005). Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 54: 357-363 [Abstract] [Full Text]  
• Radford-Smith, G L (2005). Will worms really cure Crohn's disease?. Gut 54: 6-8 [Full Text]  
• Guindi, M, Riddell, R H (2004). Indeterminate colitis. J. Clin. Pathol. 57: 1233-1244 [Abstract] [Full Text]  
• O'Reilly, C. E., O'Connor, L., Anderson, W., Harvey, P., Grant, I. R., Donaghy, J., Rowe, M., O'Mahony, P. (2004). Surveillance of Bulk Raw and Commercially Pasteurized Cows' Milk from Approved Irish Liquid-Milk Pasteurization Plants To Determine the Incidence of Mycobacterium paratuberculosis. Appl. Environ. Microbiol. 70: 5138-5144 [Abstract] [Full Text]  
• Carter, M J, Lobo, A J, Travis, S P L (2004). Guidelines for the management of inflammatory bowel disease in adults. Gut 53: v1-v16 [Full Text]  
• Molinie, F, Gower-Rousseau, C, Yzet, T, Merle, V, Grandbastien, B, Marti, R, Lerebours, E, Dupas, J-L, Colombel, J-F, Salomez, J-L, Cortot, A (2004). Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 53: 843-848 [Abstract] [Full Text]  
• Mathew, C. G., Lewis, C. M. (2004). Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 13: R161-168 [Abstract] [Full Text]  
• Weinstock, J V, Summers, R, Elliott, D E (2004). Helminths and harmony. Gut 53: 7-9 [Full Text]  
• Schurmann, M., Valentonyte, R., Hampe, J., Muller-Quernheim, J., Schwinger, E., Schreiber, S. (2003). CARD15 gene mutations in sarcoidosis. Eur Respir J 22: 748-754 [Abstract] [Full Text]  
• Sood, A, Midha, V, Sood, N, Bhatia, A S, Avasthi, G (2003). Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 52: 1587-1590 [Abstract] [Full Text]  
• Jonkers, D., Stockbrugger, R. (2003). Probiotics and inflammatory bowel disease. JRSM 96: 167-171 [Full Text]  
• Elliott, D. E., Li, J., Blum, A., Metwali, A., Qadir, K., Urban, J. F. Jr., Weinstock, J. V. (2003). Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G385-G391 [Abstract] [Full Text]  
• Bach, J.-F. (2002). The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases. NEJM 347: 911-920 [Full Text]  
• Hampe, J., Frenzel, H., Mirza, M. M., Croucher, P. J. P., Cuthbert, A., Mascheretti, S., Huse, K., Platzer, M., Bridger, S., Meyer, B., Nurnberg, P., Stokkers, P., Krawczak, M., Mathew, C. G., Curran, M., Schreiber, S. (2001). Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc. Natl. Acad. Sci. USA 10.1073/pnas.261567999v1 [Abstract] [Full Text]  
• ELLIOTT, D. E., URBAN, J. F. JR., ARGO, C. K., WEINSTOCK, J. V. (2000). Does the failure to acquire helminthic parasites predispose to Crohn's disease?. FASEB J. 14: 1848-1855 [Abstract] [Full Text]  
• Loftus, E V Jr, Silverstein, M D, Sandborn, W J, Tremaine, W J, Harmsen, W S, Zinsmeister, A R (2000). Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 46: 336-343 [Abstract] [Full Text]  
• LOGAN, R. F A (1998). Inflammatory bowel disease incidence: up, down or unchanged?. Gut 42: 309-311 [Full Text]  
• Hampe, J., Frenzel, H., Mirza, M. M., Croucher, P. J. P., Cuthbert, A., Mascheretti, S., Huse, K., Platzer, M., Bridger, S., Meyer, B., Nurnberg, P., Stokkers, P., Krawczak, M., Mathew, C. G., Curran, M., Schreiber, S. (2002). Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc. Natl. Acad. Sci. USA 99: 321-326 [Abstract] [Full Text]